Possible origins of pancreatic cancer revealed

Study results: MIT cancer biologists have identified a subpopulation of cells that can give rise to pancreatic cancer. They also found that tumors can form in other, more mature pancreatic cell types, but only when they are injured or inflamed, suggesting that pancreatic cancer can arise from different types of cells depending on the circumstances.

Why it matters: There are few good treatment options for pancreatic cancer, which kills an estimated 35,000 Americans per year — making it the country’s fourth-leading cause of cancer death. Learning more about the origins of pancreatic cancer cells could help scientists develop better treatments and tools for early diagnosis.

“By the time pancreatic disease is typically diagnosed, it’s already very advanced and non-curable. Our new findings can help scientists focus their drug development efforts and lead them to new ways to detect the disease in early stages,” says Sharon Friedlander, a postdoctoral associate at MIT’s David H. Koch Institute for Integrative Cancer Research and lead author of a paper describing the work in the Nov. 3 issue of Cancer Cell.

How they did it: The team found that in mice, tumors originate from a subpopulation of pancreatic cells that express a protein called pdx1. This protein plays a critical role in pancreas development and differentiation, a process of specialization that normally occurs during embryonic development but can also occur later in life. This suggests that under normal conditions, pancreatic cancer may arise from a type of adult stem cell that can differentiate into mature pancreatic cells, says Friedlander.

When the cancer-promoting gene K-ras, commonly activated in tumors, was turned on in the pdx1-expressing cells, they became cancerous. However, mature pancreatic cells, such as insulin-secreting cells, became cancerous only when they expressed K-ras and also suffered from chronic inflammation. Under these conditions, the insulin-secreting cells became another cell type, a condition that appears necessary before they can initiate pancreatic cancer.

Next steps: In future studies, the MIT researchers plan to use their mouse models to follow the molecular events that take place during pancreatic cancer development and identify potential targets for drug treatments and protein markers for early diagnosis. These new mouse models could also help researchers test potential pancreatic cancer treatments.

###

Source: “Context-dependent transformation of adult pancreatic cells by oncogenic K-ras,” Sharon Gidekel Friedlander, Tyler Jacks, et al. Cancer Cell, Nov. 3 issue.

---
Contact: Jen Hirsch

617-253-1682
Massachusetts Institute of Technology

RELATED STORIES:
Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer   Nanoscopic changes to pancreatic cells reveal cancer   New treatment combination safe for pancreatic cancer patients   New Treatment for Pancreatic Cancer Allows Life-Saving Surgery   Avastin trial for pancreatic tumors   Researchers Find Gene Therapy that Kills Pancreatic Cancer Cells   Possible Genetic Link to Pancreatic Cancer   Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others   Researchers ID Gene Involved in Pancreatic Cancer   Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy   New research improves early detection and survival for pancreatic cancer   Pancreatic cancer risk varies with smoking habits   Red meat associated with pancreatic cancer   Pancreas cancer surgery outcome worse with obesity   Gene therapy tested in pancreatic cancer studies   Study links sugary soft drinks to pancreatic cancer   Patients With Pancreatic Cancer Could be Treated   Micro Molecules Can Identify Pancreatic Cancer   Shining light on pancreatic cancer   Popular herbal supplement hinders the growth of pancreatic cancer cells   No support for routine pancreatic cancer screening   Mayo Clinic Researchers Find Oncogene is Important in Pancreatic Cancer Growth and Spread

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]